Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis

Rheumatology

Volumn 47, Issue 3, 2008, Pages 339-344

  Tynjäal̈, Pirjo ^a,b   Kotaniemi, K ^c   Lindahl, P ^d   Latva, K ^c   Aalto, K ^a   Honkanen, V ^a   Lahdenne, P ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Lohja Hospital   (Finland)

^c RHEUMATISM FOUNDATION HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Adalimumab; Anti TNF treatment; Juvenile idiopathic arthritis; Outcome assessment; Uveitis

Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; ANTIRETROVIRUS AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GROWTH HORMONE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISOLONE; SALAZOSULFAPYRIDINE; STEROID;

ABDOMINAL PAIN; ADOLESCENT; ADRENAL INSUFFICIENCY; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BACTERIAL SKIN DISEASE; CHICKENPOX; CHILD; CLINICAL ARTICLE; CONJUNCTIVITIS; DISEASE ACTIVITY; DISEASE DURATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG WITHDRAWAL; EYE INFLAMMATION; FEMALE; FOLLOW UP; GASTRITIS; HERPES ZOSTER; HUMAN; IRIDOCYCLITIS; JUVENILE RHEUMATOID ARTHRITIS; LOCAL SKIN REACTION; MALE; MENTAL DISEASE; MONOTHERAPY; OBSERVATIONAL STUDY; OTITIS MEDIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SIDE EFFECT; SINUSITIS; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT INFECTION; VAGINA CANDIDIASIS;

EID: 39449106366     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem356     Document Type: Article

References (30)

1. Kotaniemi K, Kautiainen H, Karma A, Aho K. Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: A prospective study. Ophthalmology 2001;108:2071-5.
2. Chalom EC, Goldsmith DP, Koehler MA et al. Prevalence and outcome of uveitis in a regional cohort of patients with juvenile rheumatoid arthritis. J Rheumatol 1997;24:2031-4.
3. Ozdal PC, Vianna RN, Deschenes J. Visual outcome of juvenile rheumatoid arthritis-associated uveitis in adults. Ocul Immunol Inflamm 2005;13:33-8.
4. Kump LI, Castaneda RA, Androudi SN, Reed GF, Foster CS. Visual outcomes in children with juvenile idiopathic arthritis-associated uveitis. Ophthalmology 2006;113:1874-7.
5. Kataniemi K, Aho K, Kotaniemi A. Uveitis as a cause of visual loss in arthritides and comparable conditions. J Rheumatol 2001;28:309-12.
6. Chylack LT Jr. The ocular manifestations of juvenile rheumatoid arthritis. Arthritis Rheum 1977;20:217-23.
7. Foeldvari I, Wierk A. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 2005;32:362-5.
8. Malik AR, Pavesio C. The use of low dose methotrexate in children with chronic anterior and intermediate uveitis. Br J Ophthalmol 2005;89:806-8.
9. Weiss AH, Wallace CA, Sherry DD. Methotrexate for resistant chronic uveitis in children with juvenile rheumatoid arthritis. J Pediatr 1998;133:266-8.
10. Kilmartin DJ, Forrester JV, Dirk AD. Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol 1998;82:737-42.
11. Foster CS, Tufail F, Waheed NK et al. Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol 2003;121:437-40.
12. Smith JA, Thompson DJ, Whitcup SM et al. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 2005;53:18-23.
13. Schmeling H, Homeff G. Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology 2005;44:1008-11.
14. Richards JC, Tay-Keamey ML, Murray K, Manners P. Infliximab for juvenile idiopathic arthritis-associated uveitis. Clin Experiment Ophthalmol 2005;33:461-8.
15. Rajaraman RT, Kimura Y, Li S, Haines K, Chu DS. Retrospective case review of pediatric patients with uveitis treated with infliximab. Ophthalmology 2006;113: 308-14.
16. Kahn P, Weiss M, Imundo LF, Levy DM. Favorable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology 2006;113:880-4.
17. Tynjala P, Lindahl P, Honkanen V. Lahdenne P, Kotaniemi K. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis 2007;66:548-50.
18. Saurenmann RK, Levin AV, Rose JB et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology 2006;45:982-9.
19. Biester S, Deuter C, Michels H, et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 2007;91:319-24.
20. Vazquez-Cobian LB, Flynn T, Lehman TL Adalimumab therapy for childhood uveitis. J Pediatr 2006;149:572-6.
21. Foeldvari I, Nielsen S, Kummerle-Deschner J et al. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: Results of a multinational survey. J Rheumatol 2007;34:1146-50.
22. Weinblatt ME, Keystone EC, Furst DE, Kavanaugh AF, Chartash EK, Segurado OG. Long term efficacy and safety of edalimumab plus methotrexate in patients with rheumatoid arthritis: ARMADA 4 year extended study. Ann Rheum Dis 2006;65:753-9.
23. Petty RE, Southwood TR, Manners P et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis second revision, Edmonton, 2001. J Rheumatol 2004;31:390-2.
24. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 2005;140:509-16.
25. Rao NA, Foster DJ, Spalton DJ. The Lives. Uveitis and intraocular neoplasms. In: Podos SM, Yanoff M, eds. Anterior uveitis Vol. 2. Now York, London: Gover Medical Publishing, 1992;1-19.
26. Nussenblatt RB, Whitcup SM, Palestine AG. Uveitis: Fundamentals and clinical Practice. In: Nussenblatt RB, Whitcup SM, Palestine AG, eds. Examination of the patient with uveitis, 2nd edn. St Louis: Mosby, 1996;58-68.
27. Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
28. Konttinen L, Kankaanpaa E, Luosujarvi R et al. Effectiveness of anakinra in rheumatic disease in patients naive to biological drugs or previously on TNF blocking drugs: An observational study. Clin Rheumatol 2006;25:882-4.
29. Wallace CA, Ruperto N, Giannini E et al. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004;31:2290-4.
30. Lahdenne P, Vahasalo P, Honkanen V. Infliximab or etanercept in the treatment of children wilh refractory juvenile idiopathic arthritis: An open label study. Ann Rheum Dis 2003;62:245-7.